532 completed, 111 unknown, 89 recruiting, 49 not yet recruiting. 322 Not applicable, 142 Phase 3, 98 Phase 4, 88 Phase 2, 58 Phase 1.
Follow this condition Literature Review of Migraine trials Research Report on Migraine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observational Study to Assess Migraine Prediction Tool Daily questionnaire - Migraine | Suspended | Theranica | 200 | 2030-01-01 | 2024-11-22 | |
| Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH Nortriptyline, Amitriptyline - Migraine | Phase 4 | Not yet recruiting | Sultan Qaboos University | 90 | 2027-05-01 | 2026-10-02 |
| Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial Migraine Behavioral Treatment - Migraine, Headache | Not applicable | Not yet recruiting | Mayo Clinic | 24 | 2026-12-01 | 2026-06-16 |
| Assessment of Head Awareness in Patients With Migraine in the Greek Population Migraine | Not yet recruiting | National and Kapodistrian University of Athens | 90 | 2026-11-01 | 2026-10-08 | |
| Validity and Reliability of the Greek WPAI:Migraine Migraine | Not yet recruiting | National and Kapodistrian University of Athens | 60 | 2026-11-01 | 2026-10-08 | |
| Validity and Reliability of the Greek Pain Catastrophizing Scale Migraine | Not yet recruiting | National and Kapodistrian University of Athens | 130 | 2026-11-01 | 2026-10-07 | |
| Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study gender-affirming hormone therapy, Gender-Affirming Surgery, HIV Pre-Exposure Prophylaxis - Headache, Migraine | Not yet recruiting | Chulalongkorn University | 500 | 2026-11-01 | 2026-09-14 | |
| A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine Elismetrep, Placebo - Migraine | Phase 3 | Recruiting | Kallyope Inc. | 1500 | 2026-10-02 | 2026-10-14 |
| Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth Active Remote Electrical Neuromodulation, Sham Remote Electrical Neuromodulation - Migraine, Migraine Headache | Not applicable | Not yet recruiting | University of Calgary | 30 | 2026-10-01 | 2026-08-19 |
| Migraine Characteristics and Associated Factors Observational assessment - Migraine | Not yet recruiting | Lokman Hekim University | 100 | 2026-10-01 | 2026-09-16 | |
| Behavioral Resources and Awareness for Veterans With Episodic Migraine: Impact on Neurological Disability and Quality of Life- Pilot Cognitive behavioral therapy for migraine (CBTm), MEintervention - Migraine, Migraine Headache | Not applicable | Not yet recruiting | Yale University | 24 | 2026-10-01 | 2026-08-31 |
| Headache Education and Awareness vs. Daily Mindfulness Strategies - Understanding Pain BREATHE with Headache (BREATHE-HA), Enhanced Standard-of-Care: Headache Education - Migraine, Migraine in Adolescence | Not applicable | Not yet recruiting | University of Colorado, Denver | 72 | 2026-10-01 | 2026-08-10 |
| Tear Biomarkers for Migraine Patients with migraine - Migraine | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 400 | 2026-09-30 | 2026-07-10 | |
| A Prospective Interventional Study of Intranasal Zavegepant for the Acute Treatment of Migraine Patient Headache Diary, Patient Reported Outcome, intranasal zavegepant - Migraine | Not applicable | Not yet recruiting | American Center for Psychiatry and Neurology | 250 | 2026-09-30 | 2026-10-06 |
| Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine Rimegepant 75 MG - Migraine | Not yet recruiting | Nordlandssykehuset HF | 60 | 2026-09-17 | 2026-09-21 | |
| Investigation of Imagery Abilities in Individuals With Migraine Migraine, Healthy Participants | Not yet recruiting | Hacettepe University | 126 | 2026-09-16 | 2026-09-28 | |
| Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom Migraine | Not yet recruiting | AbbVie | 200 | 2026-09-01 | 2026-07-08 | |
| Vibratory Stimulation for the Treatment of Chronic Pain Vibrotactile Stimulation, Sham Stimulation - Chronic Pain, Pelvic Pain | Not applicable | Suspended | Stanford University | 50 | 2026-09-01 | 2026-04-24 |
| Visual Instillation of Sphenopalatine-block Intervention for ONgoing Migraine Topical solution of 4% lidocaine, Saline 0.9% - Migraine, Facial Pain or Pressure | Phase 2 | Not yet recruiting | Association of Migraine Disorders | 74 | 2026-09-01 | 2026-08-14 |
| EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine Middle Meningeal Artery Embolization - Migraine Disorders, Chronic Migraine Headache | Recruiting | Cortex Neurovascular | 50 | 2026-09-01 | 2026-09-23 |
Showing 20 of 906. Sign in to see all of them.
Migraine Disorders (906) · Headache (198) · Pain (56) · Migraine with Aura (43) · Migraine without Aura (37) · Headache Disorders (25) · Tension-Type Headache (25) · Epilepsy (19) · Headache Disorders, Primary (14) · Depression (13) · Motor Activity (13) · Foramen Ovale, Patent (12) · Photophobia (12) · Headache Disorders, Secondary (11) · Multiple Sclerosis (11)
Central Nervous System Diseases (903) · Nervous System Diseases (903) · Brain Diseases (902) · Headache Disorders, Primary (892) · Headache Disorders (881) · Pathological Conditions, Signs and Symptoms (289) · Signs and Symptoms (274) · Neurologic Manifestations (265) · Pain (191) · Behavior (40) · Cardiovascular Diseases (31) · Mental Disorders (29) · Pathologic Processes (29) · Immune System Diseases (28) · Otorhinolaryngologic Diseases (23)
erenumab (42) · Topiramate (39) · rimegepant sulfate (29) · Sumatriptan (28) · eptinezumab (19) · fremanezumab (18) · galcanezumab (16) · rizatriptan (16) · Sodium Chloride (14) · Amitriptyline (12) · Naproxen (12) · lasmiditan (12) · Acupuncture Therapy (11) · ubrogepant (11) · Lidocaine (10)
Danish Headache Center (36) · Pfizer (28) · Eli Lilly and Company (20) · Amgen (18) · AbbVie (17) · H. Lundbeck A/S (15) · Theranica (15) · Merck Sharp & Dohme LLC (14) · Thomas Jefferson University (14) · Mayo Clinic (12) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (11) · Montefiore Medical Center (11) · IRCCS National Neurological Institute "C. Mondino" Foundation (10) · NYU Langone Health (10) · Cefaly Technology (7)
United States (361) · Italy (68) · Spain (58) · Denmark (55) · Germany (53) · Turkey (Türkiye) (51) · Canada (47) · China (42) · France (38) · United Kingdom (35) · Poland (30) · Belgium (29) · Japan (28) · Israel (26) · Czechia (18)
Roger K Cady, MD (6) · Cristina Tassorelli, Prof (5) · Mia Minen, MD (5) · Alit Stark Inbar, PhD (4) · Alit Stark-Inbar, PhD (4)
PMID 11914403, PMID 12807523, PMID 31482569, PMID 31952501, PMID 32576229, PMID 34264500, PMID 34928306, PMID 35076090, PMID 37303034, PMID 8984084, PMID 19486178, PMID 30462830, PMID 30594122, PMID 30942898, PMID 31253091, PMID 33069214, PMID 33143451, PMID 33413075, PMID 33544305, PMID 33549036, PMID 33950375, PMID 34049484, PMID 34819017, PMID 35139816, PMID 35331009, PMID 35471625, PMID 35779194, PMID 35978286, PMID 35979677, PMID 36038833, PMID 37965170, PMID 38581615, PMID 39221611, PMID 39982105, PMID 40275185, PMID 41235617, PMID 42129417, PMID 10221784, PMID 10449117, PMID 10778892, PMID 10946944, PMID 11167908, PMID 14728706, PMID 14982912, PMID 15096395, PMID 15316798, PMID 15622223, PMID 15724736, PMID 15870415, PMID 16183246
2019 (14), 2023 (9), 2015 (5), 2018 (4), 2008 (2), 2014 (2), 2025 (2), K01NS124911 (2), R01AT011005 (2), 1UG3AT013498-01 (1), 2005 (1), 2016 (1), K23AT008406 (1), K23AT009706 (1), K23AT013838 (1)